Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 1/20 | 0.65 |
| ▸ | ECE1 | P42892 | 1/20 | 0.65 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | PPARG | P37231 | 1/20 | 0.55 |
| ▸ | PPARA | Q07869 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | CTSK | P43235 | 2/20 | 0.54 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.54 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10192704 | 1.00 | MME (0.65) | MMEECE1FOLH1SMN1; SMN2PPARG | |
| SCHEMBL716988 | 1.00 | MME (0.65) | MMEECE1FOLH1SMN1; SMN2PPARG | |
| SCHEMBL3509748 | 1.00 | MME (0.65) | MMEECE1FOLH1SMN1; SMN2PPARG | |
| SCHEMBL11251557 | 0.99 | MME (0.64) | MMEECE1FOLH1SMN1; SMN2PPARG | |
| Glycine SCHEMBL27457065 | 0.95 | MME (0.60) | MMEECE1FOLH1SMN1; SMN2PPARG | |
| Glycine SCHEMBL7140457 | 0.95 | MME (0.60) | MMEECE1FOLH1SMN1; SMN2PPARG | |
| SCHEMBL11153005 | 0.92 | CTSL (0.61) | MMEECE1SMN1; SMN2CTSKSIRT2 | |
| SCHEMBL28993693 | 0.92 | MME (0.56) | MMEECE1SMN1; SMN2CTSK | |
| SCHEMBL4919347 | 0.92 | MME (0.56) | MMEECE1SMN1; SMN2CTSK | |
| SCHEMBL29682481 | 0.92 | MME (0.56) | MMEECE1SMN1; SMN2CTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 314 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118581600-A | Polyrotaxane/graphene oxide composite fiber and preparation method thereof | 东华大学 | 2024-09-03 | — | — | CN | claimed |
| CN-114736159-B | Photo-crosslinking molecular probe and preparation method and application thereof | 南京医科大学 | 2024-05-07 | — | — | CN | claimed |
| CN-115068666-B | Anti-adhesion hemostatic hydrogel and preparation method and application thereof | 广东粤港澳大湾区国家纳米科技创新研究院 | 2023-12-26 | — | — | CN | claimed |
| CN-116615257-A | Selenium antibody conjugates | 瑞泽恩制药公司 | 2023-08-18 | — | — | CN | claimed |
| CN-115068666-A | Anti-adhesion hemostatic hydrogel and preparation method and application thereof | 广东粤港澳大湾区国家纳米科技创新研究院 | 2022-09-20 | — | — | CN | claimed |
| CN-114736159-A | Photo-crosslinking molecular probe and preparation method and application thereof | 南京医科大学 | 2022-07-12 | — | — | CN | claimed |
| US-20220143194-A1 | SELENIUM ANTIBODY CONJUGATES | REGENERON PHARMACEUTICALS, INC. | 2022-05-12 | — | — | US | claimed |
| EP-3988538-A1 | MODIFIED HYDROPHOBIC AUXILIARY MATERIAL, PREPARATION METHOD THEREFOR AND USE THEREOF | Zhejiang Zhida Pharmaceutical Co., Ltd. (CN) | 2022-04-27 | — | — | EP | claimed |
| US-20220111055-A1 | MODIFIED HYDROPHOBIC EXCIPIENT AND PREPARATION METHOD THEREOF | ZHEJIANG ZHIDA PHARMACEUTICAL CO., LTD. (CN) | 2022-04-14 | — | — | US | claimed |
| WO-2020252713-A1 | MODIFIED HYDROPHOBIC AUXILIARY MATERIAL, PREPARATION METHOD THEREFOR AND USE THEREOF | 浙江智达药业有限公司 | 2020-12-24 | — | — | WO | claimed |
| EP-0815833-B1 | Malodour preventing agents | GIVAUDAN SA (CH) | 2003-04-09 | — | — | EP | claimed |
| US-5925339-A | ODORLESS DEODORANTS AND ANTIPERSPIRANTS | GIVAUDAN ROURE SA (CH) | 1999-07-20 | — | — | US | claimed |
| US-5757408-A | PRINTING IMAGE ON SUBSTRATE COATED WITH AMINO-ACID DERIVATIVE ADDITIVE; QUICK DRYING OF INK, OPTICAL DENSITY, NONCURLING | XEROX CORPORATION (US) | 1998-05-26 | — | — | US | claimed |
| EP-0815833-A2 | Malodour preventing agents | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 1998-01-07 | — | — | EP | claimed |
| US-5683793-A | Ink jet transparencies | XEROX CORPORATION (US) | 1997-11-04 | — | — | US | claimed |
| EP-0555046-B1 | Method for determination of calcium | ORIENTAL YEAST CO LTD (JP) | 1997-07-30 | — | — | EP | claimed |
| US-5618684-A | CALCIUM ACTIVATED TRANSGLUTAMINASE ACTS ON SUBSTRATE TO GENERATE AMMONIA; CORRELATING AMOUNT OF AMMONIA GENERATED WITH AN AMOUNT OF CALCIUM | ORIENTAL YEAST CO., LTD. (JP) | 1997-04-08 | — | — | US | claimed |
| US-5589277-A | INK JET PRINTING, AQUEOUS INKS, FAST DRYING | XEROX CORPORATION (US) | 1996-12-31 | — | — | US | claimed |
| EP-0667246-A1 | Recording sheets containing amino acids, hydroxy acids, and polycarboxyl compounds | XEROX CORPORATION (US) | 1995-08-16 | — | — | EP | claimed |
| EP-0281283-B1 | HETEROCYCLIC COMPOUNDS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-02-10 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220143194-A1 | SELENIUM ANTIBODY CONJUGATES | SCLY, SELENOI, GPX1 | MME 1420/4885ECE1 1323/4885FOLH1 118/4885 |
| US-20220111055-A1 | MODIFIED HYDROPHOBIC EXCIPIENT AND PREPARATION METHOD THEREOF | CETP, SLC43A1, SLC27A1 | MME 737/4885ECE1 834/4885FOLH1 3754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.